Our vision is that all Irish patients can afford and access the medicines they need to get well, stay well and live well.

Total spend on medicine in 2015 by the HSE was €2 billion – the largest single spend in our health service.

In terms of health expenditure per capita, Ireland ranks as the 8th highest spend amongst selected OECD countries.

Life expectancy in Ireland has increased by almost two and a half years since 2005 and has been consistently higher than the EU average throughout the last decade.

Who we are

About us

The way Ireland procures and supplies medicines is outdated and no longer fit for purpose.

Medicines for Ireland is an organisation founded and motivated by a strong desire to fix this problem.

Globally and in Ireland, the presumption of automatic access to innovative medicines is no longer guaranteed. The supply of medicines requires radical reform so that patients can access life-saving and life-enhancing treatment vital to their well-being.

Achieving reform in this critical area of patient care is a core objective of our organisation.

We are committed to working with key stakeholders to affect real change and reforms that ensure Irish patients receive the best medical treatment in the most affordable way.


David Delaney, Chairperson of Medicines for Ireland

Head of Policy & Market Access, Europe, Northern & Western Cluster, Viatris.

Board Member, Medicines for Europe, the European Pharmaceutical Trade Association.

Board Member and Director of the Irish Medicines Verification Organisation (IMVO)


Padraic O’Brien, Vice-Chairperson of Medicines for Ireland

Associate Director Commercial Ireland, Accord Healthcare Ireland

Secretary to the Board and Director of Medicines for Ireland










Medicines for Ireland,

13 Merrion Square,

Dublin 2

D02 HW89


Medicines for Ireland, 13 Merrion Square, Dublin 2 D02 HW89